Saudi Arabia Pharmaceuticals Market Report by Product Type (Prescription drugs, Over the counter (OTC) drugs), Application (Cardiovascular Diseases, Diabetes, Cancer, Obesity, Infectious Diseases, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Region 2024-2032

Saudi Arabia Pharmaceuticals Market Report by Product Type (Prescription drugs, Over the counter (OTC) drugs), Application (Cardiovascular Diseases, Diabetes, Cancer, Obesity, Infectious Diseases, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A9945
Buy Now

Market Overview: 

The Saudi Arabia pharmaceuticals market size reached US$ 9.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.5 Billion by 2032, exhibiting a growth rate (CAGR) of 2.52% during 2024-2032. The rapid population expansion, increasing healthcare needs, rising government initiatives in improving healthcare sector, inflating income levels, growing health awareness among the masses, continued investments in developing advanced medications are some of the major factors propelling the market.

Report Attribute
 Key Statistics                   
Base Year
Forecast Years
Historical Years
Market Size in 2023 US$ 9.2 Billion
Market Forecast in 2032 US$ 11.5 Billion
Market Growth Rate 2024-2032 2.52% 

Pharmaceuticals, also known as drugs or medications, are substances used to diagnose, prevent, treat, or cure diseases and medical conditions in humans and animals. These compounds are carefully developed, tested, and regulated to ensure their safety, efficacy, and quality. Pharmaceuticals encompass a broad range of products, including prescription medicines, over-the-counter drugs, vaccines, and biologics. The development of pharmaceuticals involves a complex process that typically starts with extensive research and identification of potential drug candidates. Once a promising compound is discovered, it undergoes rigorous preclinical testing in laboratories and animal studies to assess its safety and effectiveness. Subsequently, clinical trials involving human participants are conducted in multiple phases to evaluate the drug's performance, dosing, side effects, and interactions. Regulatory authorities closely scrutinize the trial data before granting approval for market authorization.

Saudi Arabia Pharmaceuticals Market

Saudi Arabia's population has been steadily increasing, leading to a rise in healthcare needs. The country's healthcare infrastructure is continually expanding to meet the growing demand for pharmaceutical products and medical services. Additionally, as with many other nations, Saudi Arabia is experiencing a rise in non-communicable diseases such as diabetes, cardiovascular disorders, and respiratory illnesses. This has created a higher demand for pharmaceuticals to manage and treat these health conditions. Other than this, increasing disposable incomes and a greater focus on health and well-being have led to higher healthcare spending and a greater willingness to purchase pharmaceutical products. Besides this, efforts to expand health insurance coverage in Saudi Arabia have made healthcare and pharmaceuticals more accessible to a broader segment of the population, leading to increased demand for medicines. In line with this, Saudi Arabia is witnessing a growing interest in biotechnology and bio-pharmaceuticals. Investments in research and development in these areas are driving the pharmaceutical market towards advanced therapies and targeted treatments. Furthermore, the government has been actively investing in its healthcare sector, including pharmaceuticals. Initiatives to improve healthcare services and promote domestic drug manufacturing have positively impacted the pharmaceuticals market.

Saudi Arabia Pharmaceuticals Market Trends/Drivers:

Growing Population and Rising Healthcare Demand

Saudi Arabia's population has been experiencing significant growth over the years, driven by factors such as high birth rates and a steady influx of expatriate workers. This population expansion has led to an increased demand for healthcare services, including pharmaceutical products. As the population ages and lifestyles change, there is a rising prevalence of chronic diseases and other health conditions, necessitating a higher consumption of medications to manage and treat these ailments. The healthcare industry, including the pharmaceutical sector, must adapt to cater to the needs of this growing population, creating opportunities for pharmaceutical companies to expand their market presence and product offerings.

Increasing Government Investment in Healthcare Sector

A substantial portion of the government's budget is allocated to healthcare, including pharmaceuticals. Government investments aim to enhance medical facilities, support research and development initiatives, and promote local drug manufacturing. Through various initiatives and programs, the government encourages the development of a vibrant pharmaceutical industry that can cater to the needs of the population and reduce reliance on imported medicines. Such investments have contributed to the growth of the pharmaceuticals market and increased accessibility to medications for the Saudi population.

Saudi Arabia Pharmaceuticals Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the Saudi Arabia pharmaceuticals market report, along with forecasts at the regional levels from 2024-2032. Our report has categorized the market based on product type, application, and distribution channel.

Breakup by Product Type:

  • Prescription drugs
    • Branded Drugs
    • Generic Drugs
  • Over the counter (OTC) drugs

The report has provided a detailed breakup and analysis of the market based on the product type. This includes prescription drugs (branded drugs and generic drugs) and over the counter (OTC) drugs.

Prescription drugs are medications that require a physician's written or electronic authorization for dispensing. These drugs are often more potent and complex than OTC drugs, addressing critical medical conditions and chronic illnesses. The prescription drug segment plays a pivotal role in providing advanced healthcare solutions to patients with specific medical needs.

On the other hand, over-the-counter drugs are medications that can be purchased directly by consumers without a prescription. These drugs typically address common health issues, such as mild pain relief, cough and cold, and digestive problems. The accessibility and convenience of OTC drugs contribute significantly to their popularity among consumers seeking immediate relief from minor ailments.

Breakup by Application:

  • Cardiovascular Diseases
  • Diabetes
  • Cancer
  • Obesity
  • Infectious Diseases
  • Others

A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes cardiovascular diseases, diabetes, cancer, obesity, infectious diseases, others.

Cardiovascular diseases refer to a group of disorders affecting the heart and blood vessels. These conditions include coronary artery disease, heart failure, arrhythmias, and hypertension. With a rising incidence of lifestyle-related risk factors, such as sedentary lifestyles, poor dietary habits, and increasing stress levels, the prevalence of cardiovascular diseases remains a major concern in many regions, including Saudi Arabia.

Diabetes is characterized by chronic hyperglycemia, resulting from insufficient insulin production or ineffective insulin utilization by the body. The two main types of diabetes are type 1 and type 2 diabetes, with the latter being more prevalent and often linked to lifestyle factors.

Cancer encompasses a wide array of diseases characterized by uncontrolled cell growth and the potential to invade surrounding tissues or spread to other parts of the body. Saudi Arabia, like the rest of the world, witnesses a growing prevalence of cancer cases, attributed to factors such as aging populations, lifestyle choices, and environmental exposures.

Obesity is a complex health issue influenced by genetic, behavioral, and environmental factors. In Saudi Arabia, as in many other countries, sedentary lifestyles, unhealthy dietary patterns, and changing socioeconomic factors contribute to the rising prevalence of obesity.

Breakup by Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

The report has provided a detailed breakup and analysis of the market based on the distribution channel. This includes hospital pharmacy, retail pharmacy, and online pharmacy.

Hospital pharmacies serve as an essential link between healthcare providers and patients, ensuring timely access to prescribed medications during hospital stays. These pharmacies are staffed by licensed pharmacists and pharmacy technicians who dispense medications, provide medication counseling to patients, and collaborate closely with healthcare teams to ensure optimal patient outcomes.

Retail pharmacies represent the most familiar and accessible distribution channel for pharmaceutical products. These pharmacies are often located in community settings, neighborhoods, and commercial areas, making them easily accessible to the general public. Retail pharmacies serve a diverse customer base, providing over-the-counter medications, prescription drugs, and a range of healthcare products.

Online pharmacies provide a digital platform for customers to purchase medications and healthcare products remotely, offering convenience and potentially lower costs. Customers can place orders through websites or mobile applications, and medications are delivered to their doorstep.

Breakup by Region:

  • Western Region
  • Northern and Central Region
  • Eastern Region
  • Southern Region

The report has also provided a comprehensive analysis of all the major regional markets, which include Western region, Northern and Central region, Eastern region and Southern region.

The Western region of Saudi Arabia comprises of provinces such as Makkah and Madinah, this region is home to major cities like Jeddah and Taif, with a considerable population and diverse healthcare needs. The Western region houses several prominent healthcare facilities, including hospitals, clinics, and research centers, contributing to the demand for pharmaceutical products and services.

The Eastern region of Saudi Arabia, comprising provinces such as Ash Sharqiyah and Al-Ahsa, holds significant importance in the pharmaceutical market. Dammam, Al-Khobar, and Jubail are major cities in this region, known for their thriving industrial and commercial sectors. The region's economic strength and rapid urbanization have contributed to an increased demand for pharmaceutical products and services.

The Southern region of Saudi Arabia is characterized by its picturesque landscapes and cultural richness, the Southern region faces distinct healthcare challenges and opportunities compared to other regions in the country.

Competitive Landscape:

Leading pharmaceutical companies operating in Saudi Arabia are investing significantly in research and development to develop new and improved drugs. These R&D initiatives focus on addressing prevalent health conditions, including chronic diseases and rare disorders, while also exploring potential breakthrough therapies. Additionally, many key players have established local manufacturing facilities within Saudi Arabia. This move is in line with the government's push for self-sufficiency in pharmaceutical production and reducing the dependence on imported drugs. By manufacturing locally, these companies can ensure a steady supply of medicines and optimize costs. Other than this, they form strategic partnerships and collaborations with local research institutions, healthcare providers, and international pharmaceutical companies. Such collaborations foster knowledge exchange, technology transfer, and access to a broader portfolio of medications. Besides this, to cater to a diverse healthcare market, pharmaceutical companies are diversifying their product offerings. This includes a focus on generic medications, branded pharmaceuticals, biologics, vaccines, and specialized therapies to address specific medical conditions.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • AstraZeneca
  • GSK plc
  • Hikma Pharmaceuticals PLC
  • Jamjoom Pharma
  • Julphar
  • Novartis AG
  • Pfizer Saudi Limited Corporate (Pfizer Inc.)
  • Sanofi KASA (Sanofi S.A.)
  • Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO)
  • Tabuk Pharmaceuticals (ASTRA Industrial Group)

Saudi Arabia Pharmaceuticals Market Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Scope of the Report Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment: 
  • Product Type
  • Application
  • Distribution Channel
  • Region 
Product Types Covered Prescription drugs, Over the counter (OTC) drugs
Applications Covered Cardiovascular Diseases, Diabetes, Cancer, Obesity, Infectious Diseases, Others
Distribution Channels Covered Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Regions Covered Western Region, Northern and Central Region, Eastern Region, Southern Reion
Companies Covered AstraZeneca, GSK Plc, Hikma Pharmaceuticals PLC, Jamjoom Pharma, Julphar, Novartis AG, Pfizer Saudi Limited Corporation (Pfizer Inc.), Sanofi KSA (Sanofi S.A.), Saudi Pharmaceutical Industries & Medical Appliances Corporation (SOIMACO), Tabuk Pharmaceuticals (ASTRA Industrial Group)
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3699
Five User License: US$ 4699
Corporate License: US$ 5699
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report:

  • How has the Saudi Arabia pharmaceuticals market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the Saudi Arabia pharmaceuticals market?
  • What is the impact of each driver, restraint, and opportunity on the Saudi Arabia pharmaceuticals market?
  • What are the key regional markets?
  • Which countries represent the most attractive Saudi Arabia pharmaceuticals market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the Saudi Arabia pharmaceuticals market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the Saudi Arabia pharmaceuticals market?
  • What is the breakup of the market based on the distribution channel?
  • Which is the most attractive distribution channel in the Saudi Arabis pharmaceuticals market?
  • What is the competitive structure of the Saudi Arabia pharmaceuticals market?
  • Who are the key players/companies in the Saudi Arabia pharmaceuticals market?

Key Benefits for Stakeholders:

  • IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Saudi Arabia pharmaceuticals market from 2018-2032.
  • The research study provides the latest information on the market drivers, challenges, and opportunities in the Saudi Arabia pharmaceuticals market.
  • The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Saudi Arabia pharmaceuticals industry and its attractiveness.
  • Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market. 

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Saudi Arabia Pharmaceuticals Market Report by Product Type (Prescription drugs, Over the counter (OTC) drugs), Application (Cardiovascular Diseases, Diabetes, Cancer, Obesity, Infectious Diseases, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Region 2024-2032
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More